• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    AdvanSix Announces Third Quarter 2025 Financial Results

    11/7/25 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials
    Get the next $ASIX alert in real time by email

    3Q25 Sales of $374 million, down 6% versus prior year

    3Q25 Earnings Per Share of ($0.10); Adjusted Earnings Per Share of $0.08

    3Q25 Cash Flow from Operations of $27 million

    AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the third quarter ending September 30, 2025. Overall, the Company continued to navigate challenging industry dynamics with a focus on optimizing operational and commercial performance.

    Third Quarter 2025 Summary

    "In the third quarter, our team executed with agility and discipline as we seasonally entered a new fertilizer year in Plant Nutrients with a strong fall fill program, amid higher raw material input costs, while continuing to realize the ongoing benefits from our SUSTAIN growth program," said Erin Kane, president and CEO of AdvanSix. "In the face of continued weak market conditions in Nylon Solutions and lower net pricing in Chemical Intermediates year over year as anticipated, we are making the strategic choice to moderate production rates to manage inventory levels with a keen focus on free cash flow. We have a demonstrated track record of navigating through cycles and complex dynamics, and our durable competitive advantage will serve us well through this time."

    Summary third quarter 2025 financial results for the Company are included below:

    ($ in Thousands, Except Earnings Per Share)

    3Q 2025

     

    3Q 2024

     

    Variance

    Sales

    $374,473

     

    $398,187

     

    ($23,714)

    Net Income (Loss)

    (2,638)

     

    22,266

     

    (24,904)

    Diluted Earnings Per Share

    (0.10)

     

    0.82

     

    (0.92)

    Adjusted Diluted Earnings Per Share (1)

    0.08

     

    0.88

     

    (0.80)

    Adjusted EBITDA (1)

    24,734

     

    53,161

     

    (28,427)

    Adjusted EBITDA Margin % (1)

    6.6%

     

    13.4%

     

    (680) bps

    Cash Flow from Operations

    26,588

     

    57,250

     

    (30,662)

    Capital Expenditures

    26,522

     

    30,490

     

    (3,968)

    Free Cash Flow (1)(2)

    66

     

    26,760

     

    (26,694)

    (1) 

    See "Non-GAAP Measures" included in this press release for non-GAAP reconciliations

    (2)

    Net cash provided by operating activities less capital expenditures

    Sales of $374 million in the quarter decreased approximately 6% versus the prior year. Sales volume decreased approximately 3% primarily driven by softer demand in chemical intermediates and nylon end markets. Raw material pass-through pricing was down approximately 5% following a net cost decrease in benzene and propylene (inputs to cumene which is a key feedstock to our products). Market-based pricing was favorable by approximately 2% driven by continued strength in Plant Nutrients reflecting favorable North American ammonium sulfate supply and demand conditions.

    Sales by product line and approximate percentage of total sales are included below:

    ($ in Thousands)

    3Q 2025

     

    3Q 2024 (1)

     

    Sales

     

    % of Total

     

    Sales

     

    % of Total

    Nylon

    $

    79,029

     

    21

    %

     

    $

    93,693

     

    24

    %

    Caprolactam

     

    73,137

     

    20

    %

     

     

    76,338

     

    19

    %

    Plant Nutrients

     

    138,661

     

    37

    %

     

     

    113,552

     

    29

    %

    Chemical Intermediates

     

    83,646

     

    22

    %

     

     

    114,604

     

    28

    %

    Total

    $

    374,473

     

    100

    %

     

    $

    398,187

     

    100

    %

    (1) The Company transferred certain products between its Chemical Intermediates product line and its Plant Nutrients product line to align more closely with its current sales structure. Historical information has been reclassified to reflect these changes for all periods presented in the Consolidated Financial Statements. Total revenue amounts were not impacted for either period.

    Adjusted EBITDA of $24.7 million in the quarter decreased $28.4 million versus the prior year primarily driven by a decline in Chemical Intermediates pricing, net of raw material costs, and the impact of lower Nylon and Chemical Intermediates sales and production volume.

    Adjusted earnings per share of $0.08 decreased $0.80 versus the prior year driven primarily by the factors discussed above.

    Cash flow from operations of $26.6 million in the quarter decreased $30.7 million versus the prior year primarily due to lower net income. Capital expenditures of $26.5 million in the quarter decreased $4.0 million versus the prior year.

    Outlook

    • Anticipate continued strength in Plant Nutrients amid higher raw material input costs supported by planned progression of SUSTAIN growth program
    • Acetone spread over refinery grade propylene costs are below 2024 multi-year highs, but expected to hold near cycle averages
    • Navigating an extended downturn in the nylon cycle - focused on controllable levers to optimize performance
    • Expect Capital Expenditures to now be approximately $120 to $125 million in 2025, reflecting $30 million of full year cash conservation through refined prioritization and focus on strong cash flow generation
    • Completed 4Q25 planned plant turnaround as expected (approximately $14 million pre-tax income impact)
    • Expect cash flow tailwind in 2026 from 45Q carbon capture tax credits and 100% bonus depreciation

    "We are well-positioned as an American manufacturer of essential chemistries serving a diverse set of end market applications with alignment to domestic agriculture, manufacturing supply chains and energy markets. The current market backdrop has been mixed. We've seen continued strength in Plant Nutrients and acetone margins remain near cycle averages, while nylon has been more challenging. In times of uncertainty, we're focused on delivering on controllable levers. This includes continued optimization of production output and sales volume mix while driving productivity to support through-cycle profitability. Taking a disciplined approach to cash management is critical reflected in our prioritization of base capital investments and we anticipate tailwinds in 2026 from 45Q carbon capture tax credits. We are committed to delivering long-term value to our shareholders," concluded Kane.

    Dividend

    The Company's Board of Directors declared a quarterly cash dividend of $0.16 per share on the Company's common stock. The dividend is payable on December 2, 2025 to stockholders of record as of the close of business on November 18, 2025.

    Conference Call Information

    AdvanSix will discuss its results during its investor conference call today starting at 9:30 a.m. ET. To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start, and tell the operator that you are dialing in for AdvanSix's third quarter 2025 earnings call. The live webcast of the investor call as well as related presentation materials can be accessed at http://investors.advansix.com. Investors can hear a replay of the conference call from 12 noon ET on Nov 7 until 12 noon ET on Nov 14 by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international). The access code is 9358968.

    About AdvanSix

    AdvanSix is a diversified chemistry company that produces essential materials for our customers in a wide variety of end markets and applications that touch people's lives. Our integrated value chain of our five U.S.-based manufacturing facilities plays a critical role in global supply chains and enables us to innovate and deliver essential products for our customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets. Guided by our core values of Safety, Integrity, Accountability and Respect, AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, plant nutrients, and chemical intermediates. More information on AdvanSix can be found at http://www.advansix.com.

    Forward Looking Statements

    This release contains certain statements that may be deemed "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements may be identified by words such as "expect," "anticipate," "estimate," "outlook," "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should" and "believe" and other variations or similar terminology and expressions. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the U.S. and globally; the potential effects of inflationary pressures, tariffs or the imposition of new tariffs, trade wars, barriers or restrictions, or threats of such actions, changes in interest rates, labor market shortages and supply chain issues; instability or volatility in financial markets or other unfavorable economic or business conditions caused by geopolitical concerns, including as a result of new or proposed legislation or regulatory, trade or other policies in or impacting the U.S., the conflict between Russia and Ukraine, the conflicts in Israel, Gaza and Iran, and related uncertainty in the surrounding region, and the possible expansion of such conflicts; the effect of any of the foregoing on our customers' demand for our products and our suppliers' ability to manufacture and deliver our raw materials, including implications of reduced refinery utilization in the U.S.; our ability to sell and provide our goods and services; the ability of our customers to pay for our products; any closures of our and our customers' offices and facilities; risks associated with increased phishing, compromised business emails and other cybersecurity attacks, data privacy incidents and disruptions to our technology infrastructure; risks associated with operating with a reduced workforce; risks associated with our indebtedness including compliance with financial and restrictive covenants, and our ability to access capital on reasonable terms, at a reasonable cost, or at all, due to economic conditions or otherwise; the impact of scheduled turnarounds and significant unplanned downtime and interruptions of production or logistics operations as a result of mechanical issues or other unanticipated events such as fires, severe weather conditions, natural disasters, pandemics, geopolitical conflicts and related events; price fluctuations, cost increases and supply of raw materials; our operations and growth projects requiring substantial capital; growth rates and cyclicality of the industries we serve including global changes in supply and demand; failure to develop and commercialize new products or technologies; loss of significant customer relationships; adverse trade and tax policies; extensive environmental, health and safety laws that apply to our operations; hazards associated with chemical manufacturing, storage and transportation; litigation associated with chemical manufacturing and our business operations generally; inability to acquire and integrate businesses, assets, products or technologies; protection of our intellectual property and proprietary information; prolonged work stoppages as a result of labor difficulties or otherwise; failure to maintain effective internal controls; our ability to declare and pay quarterly cash dividends and the amounts and timing of any future dividends; our ability to repurchase our common stock and the amount and timing of any future repurchases; disruptions in supply chain, transportation and logistics; potential for uncertainty regarding qualification for tax treatment of our spin-off; fluctuations in our stock price; and changes in laws or regulations applicable to our business. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ materially from those contemplated by such forward-looking statements as a result of a number of risks, uncertainties and other factors including those noted above and those identified in our filings with the Securities and Exchange Commission (SEC), including the risk factors in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024, as updated in subsequent reports filed with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. We do not undertake to update or revise any of our forward-looking statements.

    Non-GAAP Financial Measures

    This press release includes certain non-GAAP financial measures intended to supplement, not to act as substitutes for, comparable GAAP measures. Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in this press release. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided. Non-GAAP measures in this press release may be calculated in a way that is not comparable to similarly-titled measures reported by other companies.

     
     

    AdvanSix Inc.

    Condensed Consolidated Balance Sheets

    (Unaudited)

    (Dollars in thousands, except share and per share amounts)

     

     

    September 30, 2025

     

    December 31, 2024

    ASSETS

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    23,696

     

     

    $

    19,564

     

    Accounts and other receivables – net

     

    184,490

     

     

     

    145,673

     

    Inventories – net

     

    209,120

     

     

     

    212,386

     

    Taxes receivable

     

    23,758

     

     

     

    503

     

    Other current assets

     

    13,931

     

     

     

    8,990

     

    Total current assets

     

    454,995

     

     

     

    387,116

     

    Property, plant and equipment – net

     

    943,332

     

     

     

    917,858

     

    Operating lease right-of-use assets

     

    155,652

     

     

     

    153,438

     

    Goodwill

     

    56,192

     

     

     

    56,192

     

    Intangible assets

     

    40,857

     

     

     

    43,144

     

    Other assets

     

    37,319

     

     

     

    37,172

     

    Total assets

    $

    1,688,347

     

     

    $

    1,594,920

     

     

     

     

     

    LIABILITIES

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    236,053

     

     

    $

    228,761

     

    Accrued liabilities

     

    55,850

     

     

     

    47,264

     

    Income taxes payable

     

    49

     

     

     

    1,047

     

    Operating lease liabilities – short-term

     

    41,695

     

     

     

    42,493

     

    Deferred income and customer advances

     

    681

     

     

     

    37,538

     

    Total current liabilities

     

    334,328

     

     

     

    357,103

     

    Deferred income taxes

     

    159,758

     

     

     

    145,299

     

    Operating lease liabilities – long-term

     

    114,924

     

     

     

    111,400

     

    Line of credit – long-term

     

    250,000

     

     

     

    195,000

     

    Postretirement benefit obligations

     

    257

     

     

     

    —

     

    Other liabilities

     

    10,848

     

     

     

    11,468

     

    Total liabilities

     

    870,115

     

     

     

    820,270

     

     

     

     

     

    STOCKHOLDERS' EQUITY

     

     

     

    Common stock, par value $0.01; 200,000,000 shares authorized; 33,177,824 shares issued and 26,864,035 outstanding at September 30, 2025; 32,989,165 shares issued and 26,737,036 outstanding at December 31, 2024

     

    332

     

     

     

    330

     

    Preferred stock, par value $0.01; 50,000,000 shares authorized; 0 shares issued and outstanding at September 30, 2025 and December 31, 2024

     

    —

     

     

     

    —

     

    Treasury stock at par (6,313,789 shares at September 30, 2025; 6,252,129 shares at December 31, 2024)

     

    (63

    )

     

     

    (63

    )

    Additional paid-in capital

     

    141,876

     

     

     

    136,872

     

    Retained earnings

     

    670,264

     

     

     

    631,541

     

    Accumulated other comprehensive income

     

    5,823

     

     

     

    5,970

     

    Total stockholders' equity

     

    818,232

     

     

     

    774,650

     

    Total liabilities and stockholders' equity

    $

    1,688,347

     

     

    $

    1,594,920

     

    AdvanSix Inc.

    Condensed Consolidated Statements of Operations

    (Unaudited)

    (Dollars in thousands, except share and per share amounts)

     

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

    2025

     

    2024

     

    2025

     

    2024

    Sales

    $

    374,473

     

     

    $

    398,187

     

    $

    1,162,286

     

     

    $

    1,188,495

     

     

     

     

     

     

     

     

    Costs, expenses and other:

     

     

     

     

     

     

     

    Costs of goods sold

     

    349,088

     

     

     

    340,885

     

     

    1,024,716

     

     

     

    1,046,860

    Selling, general and administrative expenses

     

    27,425

     

     

     

    24,265

     

     

    76,250

     

     

     

    72,290

    Interest expense, net

     

    2,322

     

     

     

    2,924

     

     

    6,119

     

     

     

    9,137

    Other non-operating (income) expense, net

     

    (815

    )

     

     

    368

     

     

    (1,831

    )

     

     

    1,808

    Total costs, expenses and other

     

    378,020

     

     

     

    368,442

     

     

    1,105,254

     

     

     

    1,130,095

     

     

     

     

     

     

     

     

    Income (loss) before taxes

     

    (3,547

    )

     

     

    29,745

     

     

    57,032

     

     

     

    58,400

    Income tax expense (benefit)

     

    (909

    )

     

     

    7,479

     

     

    4,955

     

     

     

    14,603

    Net income (loss)

    $

    (2,638

    )

     

    $

    22,266

     

    $

    52,077

     

     

    $

    43,797

     

     

     

     

     

     

     

     

    Earnings per common share

     

     

     

     

     

     

     

    Basic

    $

    (0.10

    )

     

    $

    0.83

     

    $

    1.94

     

     

    $

    1.63

    Diluted

    $

    (0.10

    )

     

    $

    0.82

     

    $

    1.91

     

     

    $

    1.61

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding

     

     

     

     

     

     

     

    Basic

     

    26,927,305

     

     

     

    26,790,752

     

     

    26,887,489

     

     

     

    26,836,114

    Diluted

     

    26,927,305

     

     

     

    27,204,714

     

     

    27,248,759

     

     

     

    27,209,680

    AdvanSix Inc.

    Condensed Consolidated Statements of Cash Flows

    (Unaudited)

    (Dollars in thousands)

     

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

    2025

     

    2024

     

    2025

     

    2024

    Cash flows from operating activities:

     

     

     

     

     

     

     

    Net income (loss)

    $

    (2,638

    )

     

    $

    22,266

     

     

    $

    52,077

     

     

    $

    43,797

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

     

     

     

     

    Depreciation and amortization

     

    20,327

     

     

     

    18,933

     

     

     

    58,966

     

     

     

    57,197

     

    (Gain) loss on disposal of assets

     

    —

     

     

     

    154

     

     

     

    (177

    )

     

     

    415

     

    Deferred income taxes

     

    7,820

     

     

     

    2,887

     

     

     

    14,466

     

     

     

    3,638

     

    Stock-based compensation

     

    1,632

     

     

     

    1,559

     

     

     

    5,919

     

     

     

    5,963

     

    Amortization of deferred financing fees

     

    155

     

     

     

    155

     

     

     

    464

     

     

     

    464

     

    Operational asset adjustments

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    1,200

     

    Changes in assets and liabilities, net of business acquisitions:

     

     

     

     

     

     

     

    Accounts and other receivables

     

    (24,977

    )

     

     

    21,073

     

     

     

    (38,971

    )

     

     

    15,069

     

    Inventories

     

    12,644

     

     

     

    (37,607

    )

     

     

    3,266

     

     

     

    (1,603

    )

    Taxes receivable

     

    (8,515

    )

     

     

    (196

    )

     

     

    (23,255

    )

     

     

    1,059

     

    Accounts payable

     

    4,123

     

     

     

    17,994

     

     

     

    16,546

     

     

     

    (43,687

    )

    Income taxes payable

     

    (335

    )

     

     

    (572

    )

     

     

    (998

    )

     

     

    (7,598

    )

    Accrued liabilities

     

    8,352

     

     

     

    4,839

     

     

     

    8,913

     

     

     

    10,988

     

    Deferred income and customer advances

     

    (1,177

    )

     

     

    369

     

     

     

    (36,857

    )

     

     

    (14,161

    )

    Other assets and liabilities

     

    9,177

     

     

     

    5,396

     

     

     

    (1,218

    )

     

     

    (1,493

    )

    Net cash provided by operating activities

     

    26,588

     

     

     

    57,250

     

     

     

    59,141

     

     

     

    71,248

     

     

     

     

     

     

     

     

     

    Cash flows from investing activities:

     

     

     

     

     

     

     

    Expenditures for property, plant and equipment

     

    (26,522

    )

     

     

    (30,490

    )

     

     

    (88,849

    )

     

     

    (99,373

    )

    Other investing activities

     

    (262

    )

     

     

    (2,317

    )

     

     

    (6,153

    )

     

     

    (6,053

    )

    Net cash used for investing activities

     

    (26,784

    )

     

     

    (32,807

    )

     

     

    (95,002

    )

     

     

    (105,426

    )

     

     

     

     

     

     

     

     

    Cash flows from financing activities:

     

     

     

     

     

     

     

    Borrowings from line of credit

     

    85,000

     

     

     

    54,000

     

     

     

    316,500

     

     

     

    311,500

     

    Repayments of line of credit

     

    (75,000

    )

     

     

    (69,000

    )

     

     

    (261,500

    )

     

     

    (266,500

    )

    Principal payments of finance leases

     

    (249

    )

     

     

    (260

    )

     

     

    (740

    )

     

     

    (762

    )

    Dividend payments

     

    (4,296

    )

     

     

    (4,276

    )

     

     

    (12,876

    )

     

     

    (12,858

    )

    Purchase of treasury stock

     

    (121

    )

     

     

    (42

    )

     

     

    (1,658

    )

     

     

    (10,427

    )

    Issuance of common stock

     

    112

     

     

     

    328

     

     

     

    267

     

     

     

    755

     

    Net cash provided by (used for) financing activities

     

    5,446

     

     

     

    (19,250

    )

     

     

    39,993

     

     

     

    21,708

     

     

     

     

     

     

     

     

     

    Net change in cash and cash equivalents

     

    5,250

     

     

     

    5,193

     

     

     

    4,132

     

     

     

    (12,470

    )

    Cash and cash equivalents at beginning of period

     

    18,446

     

     

     

    12,105

     

     

     

    19,564

     

     

     

    29,768

     

    Cash and cash equivalents at the end of period

    $

    23,696

     

     

    $

    17,298

     

     

    $

    23,696

     

     

    $

    17,298

     

     

     

     

     

     

     

     

     

    Supplemental non-cash investing activities:

     

     

     

     

     

     

     

    Capital expenditures included in accounts payable

     

     

     

     

    $

    14,894

     

     

    $

    15,018

     

    AdvanSix Inc.

    Non-GAAP Measures

    (Dollars in thousands, except share and per share amounts)

    Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow

     

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

    2025

     

    2024

     

    2025

     

    2024

    Net cash provided by operating activities

    $

    26,588

     

     

    $

    57,250

     

     

    $

    59,141

     

     

    $

    71,248

     

    Expenditures for property, plant and equipment

     

    (26,522

    )

     

     

    (30,490

    )

     

     

    (88,849

    )

     

     

    (99,373

    )

    Free cash flow (1)

    $

    66

     

     

    $

    26,760

     

     

    $

    (29,708

    )

     

    $

    (28,125

    )

     

     

     

     

     

     

     

     

    (1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment.

    The Company believes that this metric is useful to investors and management as a measure to evaluate our ability to generate cash flow from business operations and the impact that this cash flow has on our liquidity.

    Reconciliation of Net Income to Adjusted EBITDA and Earnings Per Share to Adjusted Earnings Per Share

     

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

    2025

     

    2024

     

    2025

     

    2024

    Net income (loss)

    $

    (2,638

    )

     

    $

    22,266

     

     

    $

    52,077

     

     

    $

    43,797

     

    Non-cash stock-based compensation

     

    1,632

     

     

     

    1,559

     

     

     

    5,919

     

     

     

    5,963

     

    Non-recurring, unusual or extraordinary expense (2)

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    1,200

     

    Non-cash amortization from acquisitions

     

    532

     

     

     

    531

     

     

     

    1,595

     

     

     

    1,595

     

    Strategic advisory and professional fees (3)

     

    4,000

     

     

     

    —

     

     

     

    4,000

     

     

     

    —

     

    Income tax benefit relating to reconciling items

     

    (1,378

    )

     

     

    (367

    )

     

     

    (2,287

    )

     

     

    (1,594

    )

    Adjusted Net income (non-GAAP)

     

    2,148

     

     

     

    23,989

     

     

     

    61,304

     

     

     

    50,961

     

    Interest expense, net

     

    2,322

     

     

     

    2,924

     

     

     

    6,119

     

     

     

    9,137

     

    Income tax expense - Adjusted

     

    469

     

     

     

    7,846

     

     

     

    7,242

     

     

     

    16,197

     

    Depreciation and amortization - Adjusted

     

    19,795

     

     

     

    18,402

     

     

     

    57,371

     

     

     

    55,602

     

    Adjusted EBITDA (non-GAAP)

    $

    24,734

     

     

    $

    53,161

     

     

    $

    132,036

     

     

    $

    131,897

     

     

     

     

     

     

     

     

     

    Sales

    $

    374,473

     

     

    $

    398,187

     

     

    $

    1,162,286

     

     

    $

    1,188,495

     

     

     

     

     

     

     

     

     

    Adjusted EBITDA Margin (non-GAAP) (4)

     

    6.6

    %

     

     

    13.4

    %

     

     

    11.4

    %

     

     

    11.1

    %

     

     

     

     

     

     

     

     

    (2) 2024 includes a pre-tax loss of approximately $1.2 million from the reduction of the Company's anticipated receivable related to the gain on the termination fee recorded upon the exit from the Oben Holding Group S.A. alliance during the third quarter of 2023

    (3) Legal and professional fees associated with strategic regulatory matters and potential inorganic growth options

    (4) Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Sales

     

    Three Months Ended

    September 30,

     

    Nine Months Ended

    September 30,

     

    2025

     

    2024

     

     

    2025

     

    2024

    Net income (loss)

    $

    (2,638

    )

     

    $

    22,266

     

    $

    52,077

     

    $

    43,797

    Adjusted Net income (non-GAAP)

     

    2,148

     

     

     

    23,989

     

     

    61,304

     

     

    50,961

     

     

     

     

     

     

     

     

    Weighted-average number of common shares outstanding - basic

     

    26,927,305

     

     

     

    26,790,752

     

     

    26,887,489

     

     

    26,836,114

    Dilutive effect of equity awards and other stock-based holdings

     

    —

     

     

     

    413,962

     

     

    361,270

     

     

    373,566

    Weighted-average number of common shares outstanding - diluted

     

    26,927,305

     

     

     

    27,204,714

     

     

    27,248,759

     

     

    27,209,680

     

     

     

     

     

     

     

     

    EPS - Basic

    $

    (0.10

    )

     

    $

    0.83

     

    $

    1.94

     

    $

    1.63

    EPS - Diluted

    $

    (0.10

    )

     

    $

    0.82

     

    $

    1.91

     

    $

    1.61

    Adjusted EPS - Basic (non-GAAP)

    $

    0.08

     

     

    $

    0.90

     

    $

    2.28

     

    $

    1.90

    Adjusted EPS - Diluted (non-GAAP)

    $

    0.08

     

     

    $

    0.88

     

    $

    2.25

     

    $

    1.87

         

    The Company believes the non-GAAP financial measures presented in this release provide meaningful supplemental information as they are used by the Company's management to evaluate the Company's operating performance, enhance a reader's understanding of the financial performance of the Company, and facilitate a better comparison among fiscal periods and performance relative to its competitors, as these non-GAAP measures exclude items that are not considered core to the Company's operations.

    AdvanSix Inc.

    Appendix

    (Pre-tax income impact, Dollars in millions)

    Planned Plant Turnaround Schedule (4)

     

     

    1Q

    2Q

    3Q

    4Q

    FY

    Primary Unit Operation

    2017

    —

    ~$10

    ~$4

    ~$20

    ~$34

    Sulfuric Acid

    2018

    ~$2

    ~$10

    ~$30

    —

    ~$42

    Ammonia

    2019

    —

    ~$5

    ~$5

    ~$25

    ~$35

    Sulfuric Acid

    2020

    ~$2

    ~$7

    ~$20

    ~$2

    ~$31

    Ammonia

    2021

    ~$3

    ~$8

    —

    ~$18

    ~$29

    Sulfuric Acid

    2022

    ~$1

    ~$5

    ~$44(5)

    —

    ~$50

    Ammonia

    2023

    ~$2

    ~$1

    ~$27

    —

    ~$30

    Sulfuric Acid

    2024

    ~$5

    ~$3

    ~$3

    ~$47(6)

    ~$58

    Ammonia

    2025E

    ~$5

    ~$6

    —

    ~$14

    ~$25

    Sulfuric Acid

    (4) Primarily reflects the impact of fixed cost absorption, maintenance expense, and the purchase of feedstocks which are normally manufactured by the Company.

    (5) During the multi-site planned plant turnaround, additional required maintenance at our Frankford phenol plant contributed to reduced production across our integrated value chain and a delayed ramp to full operating rates at our Hopewell and Chesterfield sites, resulting in an incremental $15 million unfavorable impact to pre-tax income, which is reflected in this amount and is inclusive of fixed cost absorption, higher maintenance expense and lost sales.

    (6) During the multi-site planned plant turnaround, additional required maintenance at our Hopewell plant contributed to reduced production across our integrated value chain and a delayed ramp to full operating rates, resulting in an incremental approximately $17 million unfavorable impact to pre-tax income, which is reflected in this amount and is inclusive of fixed cost absorption, higher maintenance expense, and lost sales.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251106886066/en/

    Media

    Janeen Lawlor

    (973) 526-1615

    [email protected]

    Investors

    Adam Kressel

    (973) 526-1700

    [email protected]

    Get the next $ASIX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASIX

    DatePrice TargetRatingAnalyst
    5/19/2025$32.00Neutral → Overweight
    Piper Sandler
    4/7/2025$26.00Overweight → Neutral
    Piper Sandler
    11/12/2021$58.00Overweight
    Piper Sandler
    More analyst ratings

    $ASIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AdvanSix upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded AdvanSix from Neutral to Overweight and set a new price target of $32.00

    5/19/25 8:45:52 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded AdvanSix from Overweight to Neutral and set a new price target of $26.00

    4/7/25 8:48:39 AM ET
    $ASIX
    Major Chemicals
    Industrials

    Piper Sandler initiated coverage on AdvanSix with a new price target

    Piper Sandler initiated coverage of AdvanSix with a rating of Overweight and set a new price target of $58.00

    11/12/21 4:57:29 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    SEC Filings

    View All

    SEC Form 10-Q filed by AdvanSix Inc.

    10-Q - AdvanSix Inc. (0001673985) (Filer)

    11/7/25 4:07:47 PM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - AdvanSix Inc. (0001673985) (Filer)

    11/7/25 6:31:12 AM ET
    $ASIX
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by AdvanSix Inc.

    SCHEDULE 13G/A - AdvanSix Inc. (0001673985) (Subject)

    10/30/25 9:57:19 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Newman Donald P bought $149,089 worth of shares (5,030 units at $29.64) (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    11/19/24 4:20:20 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, General Counsel Kintiroglou Achilles B. sold $11,540 worth of shares (577 units at $20.00), decreasing direct ownership by 2% to 30,265 units (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    10/3/25 4:27:51 PM ET
    $ASIX
    Major Chemicals
    Industrials

    Director Williams Patrick was granted 677 shares, increasing direct ownership by 2% to 34,965 units (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    10/1/25 4:55:50 PM ET
    $ASIX
    Major Chemicals
    Industrials

    Director Newman Donald P was granted 1,418 shares, increasing direct ownership by 12% to 13,497 units (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    10/1/25 4:54:06 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    AdvanSix Announces Third Quarter 2025 Financial Results

    3Q25 Sales of $374 million, down 6% versus prior year 3Q25 Earnings Per Share of ($0.10); Adjusted Earnings Per Share of $0.08 3Q25 Cash Flow from Operations of $27 million AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the third quarter ending September 30, 2025. Overall, the Company continued to navigate challenging industry dynamics with a focus on optimizing operational and commercial performance. Third Quarter 2025 Summary "In the third quarter, our team executed with agility and discipline as we seasonally entered a new fertilizer year in Plant Nutrients with a strong fall fill program, amid higher raw material input costs, while

    11/7/25 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix to Release Third Quarter Financial Results and Hold Investor Conference Call on November 7

    AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its third quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, November 7. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's third quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on November 7 until 12 noon ET on November 14. You can listen to the replay by dialin

    10/14/25 6:50:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Leadership Updates

    Live Leadership Updates

    View All

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    AdvanSix Appoints Dana O'Brien and Daryl Roberts to Board of Directors

    AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Dana O'Brien and Daryl Roberts as new independent members of its Board of Directors. Ms. O'Brien recently retired as Senior Vice President and Chief Legal Officer of Olin Corporation, a leading vertically integrated global manufacturer and distributor of chemical products. Ms. O'Brien will serve on the Nominating and Governance Committee and the Compensation and Leadership Development Committee of the Board. Mr. Roberts is currently Senior Vice President and Chief Operations and Engineering Officer of DuPont de Nemours Inc., a global innovation leader with technology-based materials and solutions t

    9/2/25 4:15:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Appoints Sidd Manjeshwar as Senior Vice President and Chief Financial Officer

    AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Sidd Manjeshwar as Senior Vice President and Chief Financial Officer, effective October 1st. In this role, Mr. Manjeshwar will have global responsibility for controllership, treasury, investor relations, procurement, internal audit, commercial finance, tax and financial planning and analysis for the enterprise. Mr. Manjeshwar will report directly to Erin Kane, President and CEO of AdvanSix, and be a member of the Company's executive leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911629335/en/Sidd Manjeshwar, incoming SVP

    9/12/24 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Financials

    Live finance-specific insights

    View All

    AdvanSix Announces Third Quarter 2025 Financial Results

    3Q25 Sales of $374 million, down 6% versus prior year 3Q25 Earnings Per Share of ($0.10); Adjusted Earnings Per Share of $0.08 3Q25 Cash Flow from Operations of $27 million AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the third quarter ending September 30, 2025. Overall, the Company continued to navigate challenging industry dynamics with a focus on optimizing operational and commercial performance. Third Quarter 2025 Summary "In the third quarter, our team executed with agility and discipline as we seasonally entered a new fertilizer year in Plant Nutrients with a strong fall fill program, amid higher raw material input costs, while

    11/7/25 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix to Release Third Quarter Financial Results and Hold Investor Conference Call on November 7

    AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its third quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, November 7. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's third quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on November 7 until 12 noon ET on November 14. You can listen to the replay by dialin

    10/14/25 6:50:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Announces Second Quarter 2025 Financial Results

    2Q25 Sales of $410 million, down 10% versus prior year 2Q25 Earnings Per Share of $1.15; Adjusted Earnings Per Share of $1.24 2Q25 Cash Flow from Operations of $21 million $8 million of 45Q carbon capture tax credits claimed in 2Q25 AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the second quarter ending June 30, 2025. Overall, the Company delivered resilient earnings with strong sequential improvement and executed key growth and enterprise initiatives to support long-term sustainable performance. Second Quarter 2025 Summary "Our resilient second quarter results reflect our collective organization's execution and the advantages of

    8/1/25 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

    SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

    2/13/24 4:55:58 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

    SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

    2/9/24 9:58:57 AM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by AdvanSix Inc.

    SC 13G - AdvanSix Inc. (0001673985) (Subject)

    2/7/24 8:39:58 AM ET
    $ASIX
    Major Chemicals
    Industrials